Clinical Trial Update: Safety and Immunogenicity of Sequential Rotavirus Vaccine Schedules [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update reports safety and immunogenicity of sequential rotavirus vaccine schedules with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rotavirus Infection

Drugs mentioned

• Rotavirus vaccine (rotavirus vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Rotavirus Infection | Phase 4 | Status: COMPLETED | Results posted: 2014-10-28